Search research articles
Contact Us
Filters
Showing results (191-200 of 250) with videos related to
Page
of 25
Sort By:
Cancer Research and Treatment
|
November 10, 2020
Adjuvant Chemotherapy for Resected Ampulla of Vater Carcinoma: Retrospective Analysis of 646 Patients
Jwa Hoon Kim, Jae Ho Jeong, Baek-Yeol Ryoo, et al.
Cancers
|
March 10, 2022
Stereotactic Body Radiation Therapy versus Concurrent Chemoradiotherapy for Locally Advanced Pancreatic Cancer: A Propensity Score-Matched Analysis
Young Seob Shin, Hee Hyun Park, Jin-Hong Park, et al.
Cancers
|
March 1, 2019
Clinical Outcomes of Conversion Surgery after Neoadjuvant Chemotherapy in Patients with Borderline Resectable and Locally Advanced Unresectable Pancreatic Cancer: A Single-Center, Retrospective Analysis
Changhoon Yoo, Sang Hyun Shin, Kyu-Pyo Kim, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
February 23, 2024
Clinical outcomes of second-line therapy following disease progression on first-line modified FOLFIRINOX for borderline resectable and locally advanced pancreatic adenocarcinoma
Hyunseok Yoon, Yeokyeong Shin, Baek-Yeol Ryoo, et al.
Therapeutic Advances in Medical Oncology
|
May 16, 2022
Real-world outcomes of adjuvant gemcitabine <i>versus</i> gemcitabine plus capecitabine for resected pancreatic ductal adenocarcinoma
Sora Kang, Changhoon Yoo, So Heun Lee, et al.
Cancer Research and Treatment
|
March 14, 2023
Survival Benefit of Adjuvant Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma Who Underwent Surgery Following Neoadjuvant FOLFIRINOX
So Heun Lee, Dae Wook Hwang, Changhoon Yoo, et al.
The International Journal of Biological Markers
|
June 8, 2018
Prognostic implications of hepatitis B virus infection in intrahepatic cholangiocarcinoma treated with first-line gemcitabine plus cisplatin
Heejung Chae, Hyungwoo Cho, Changhoon Yoo, et al.
Investigational New Drugs
|
April 5, 2018
Nab-paclitaxel plus gemcitabine versus FOLFIRINOX as the first-line chemotherapy for patients with metastatic pancreatic cancer: retrospective analysis
Jihoon Kang, Inhwan Hwang, Changhoon Yoo, et al.
Therapeutic Advances in Medical Oncology
|
September 28, 2020
FOLFIRINOX in borderline resectable and locally advanced unresectable pancreatic adenocarcinoma
Changhoon Yoo, Inhwan Hwang, Tae Jun Song, et al.
Investigational New Drugs
|
August 8, 2017
Germline BRCA mutations in Asian patients with pancreatic adenocarcinoma: a prospective study evaluating risk category for genetic testing
Kyoungmin Lee, Changhoon Yoo, Kyu-Pyo Kim, et al.
Page
of 25
Search research articles
Search
Showing results (191-200 of 250) with videos related to
Sort By:
Page
of 25
Cancer Research and Treatment
|
November 10, 2020
Adjuvant Chemotherapy for Resected Ampulla of Vater Carcinoma: Retrospective Analysis of 646 Patients
Jwa Hoon Kim, Jae Ho Jeong, Baek-Yeol Ryoo, et al.
Cancers
|
March 10, 2022
Stereotactic Body Radiation Therapy versus Concurrent Chemoradiotherapy for Locally Advanced Pancreatic Cancer: A Propensity Score-Matched Analysis
Young Seob Shin, Hee Hyun Park, Jin-Hong Park, et al.
Cancers
|
March 1, 2019
Clinical Outcomes of Conversion Surgery after Neoadjuvant Chemotherapy in Patients with Borderline Resectable and Locally Advanced Unresectable Pancreatic Cancer: A Single-Center, Retrospective Analysis
Changhoon Yoo, Sang Hyun Shin, Kyu-Pyo Kim, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
February 23, 2024
Clinical outcomes of second-line therapy following disease progression on first-line modified FOLFIRINOX for borderline resectable and locally advanced pancreatic adenocarcinoma
Hyunseok Yoon, Yeokyeong Shin, Baek-Yeol Ryoo, et al.
Therapeutic Advances in Medical Oncology
|
May 16, 2022
Real-world outcomes of adjuvant gemcitabine <i>versus</i> gemcitabine plus capecitabine for resected pancreatic ductal adenocarcinoma
Sora Kang, Changhoon Yoo, So Heun Lee, et al.
Cancer Research and Treatment
|
March 14, 2023
Survival Benefit of Adjuvant Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma Who Underwent Surgery Following Neoadjuvant FOLFIRINOX
So Heun Lee, Dae Wook Hwang, Changhoon Yoo, et al.
The International Journal of Biological Markers
|
June 8, 2018
Prognostic implications of hepatitis B virus infection in intrahepatic cholangiocarcinoma treated with first-line gemcitabine plus cisplatin
Heejung Chae, Hyungwoo Cho, Changhoon Yoo, et al.
Investigational New Drugs
|
April 5, 2018
Nab-paclitaxel plus gemcitabine versus FOLFIRINOX as the first-line chemotherapy for patients with metastatic pancreatic cancer: retrospective analysis
Jihoon Kang, Inhwan Hwang, Changhoon Yoo, et al.
Therapeutic Advances in Medical Oncology
|
September 28, 2020
FOLFIRINOX in borderline resectable and locally advanced unresectable pancreatic adenocarcinoma
Changhoon Yoo, Inhwan Hwang, Tae Jun Song, et al.
Investigational New Drugs
|
August 8, 2017
Germline BRCA mutations in Asian patients with pancreatic adenocarcinoma: a prospective study evaluating risk category for genetic testing
Kyoungmin Lee, Changhoon Yoo, Kyu-Pyo Kim, et al.
Page
of 25